Positions 76–100 of 130.
Asking properly rather than in a comment on somebody else’s thread: why does nobody talk about Zepbound. Vials and pens carry the same molecule; what differs is fill…
Right: is 93.7% actually fine or am I being sold a rounding error. I paid for this one myself, nobody sent me anything, and the receipts are in the comments. The…
Short version of the title, which is already short: ERP vs SGN on the same compound, same month — both cleared 98.0%. Longer version underneath. Pulling the figures out…
Six-word version is the title — 66 weeks on 15mg, full numbers, ask me anything boring — and the rest is context. 66 weeks and 15mg. Those are measured, not estimated,…
Reference standards, analytical reagents and system-suitability material. If you are running your own method, start with a known.
Reference standardswe are measuring Mounjaro at the wrong time and calling it noise — a position I have arrived at slowly and would like tested. On comparing yourself with the trial…
SURMOUNT — what am I missing here. If this has been answered properly somewhere, link me and I will delete. Research-use-only material is not approved for human use.…
Explainer, as requested in the last thread: GIP is not what most of this community thinks it is. Vials and pens carry the same molecule; what differs is fill volume,…
stalled for 18 weeks at 12.5mg and I refuse to panic this time — a position I have arrived at slowly and would like tested. To save the first four comments: 18 weeks…
Zepbound — what am I missing here. I would rather ask a basic question now than get this wrong quietly for two months. Held 7.5 for five months. Everyone kept asking…
The title is the whole question — how much of what we believe about dual agonist actually comes from GIP threads — but here is why I am asking. The distribution matters…
genuine question about tirzepatide that I am slightly embarrassed to ask. If this has been answered properly somewhere, link me and I will delete. Research-use-only…
47 weeks, 15kg, and GIP was the hard part. Same spreadsheet I have been keeping since the start, nothing retrofitted. Since the title puts numbers in the shop window:…
help me understand 15mg, I have read the wiki twice. I would rather ask a basic question now than get this wrong quietly for two months. 15mg. Those are measured, not…
Genuine question, and the title is the question: can we stop arguing about GIP until somebody posts a number. Week 47 was the first time the scale moved after a…
what changed for me between month 6 and month 14. Searched first, found three threads that contradict each other, hence the post. Appetite effect for me is flat across…
Send the vial, get the number. Third-party purity and identity testing, results published to you regardless of what they say.
Test a vialSponsoredEst. 1998. ISO 9001 and cGMP, 1,500+ staff, 200+ patents. There is a fair chance the vial you are about to send for testing started here. Batch-specific COA as standard.
glbiochem.netAsking properly rather than in a comment on somebody else’s thread: how do you actually verify Mounjaro. On comparing yourself with the trial number. SURMOUNT-1…
Thinking out loud about this: 15mg — my 12-week log, condensed into one table. The relevant figures are 15mg, and they come from the same log I have kept the whole…
The title is the argument: dual agonist is doing more work than we give it credit for. Here is the rest of it. The distribution matters more than the mean. In the trial…
anyone else notice GIP kicking in around week 81, logged the same way every week so the comparison is at least internally fair. Sulphur burps for the first eight days…
small win: dual agonist stopped being a problem at week 50, and the part I actually want to talk about is at the bottom. Week 7 was the first time the scale moved after…
can we stop arguing about Zepbound until somebody posts a number. I am not trying to be the "source?" guy. I would just like a source. Sulphur burps for the first eight…
Posting this as a discussion rather than a claim: the GIP advice in here is 2 years out of date. To save the first four comments: 2 years. The step schedule question,…
my ApoB moved and I cannot work out whether SURPASS is why. Change my mind, genuinely — I have no stake in being right about this. Switching from semaglutide, since…
the SURPASS rule is doing its job and people should stop complaining, and here is what changes in practice if it goes ahead. SURMOUNT-1 ran 72 weeks with the top arm…
Posting this because the title is the whole finding — 22th independent test on WXT — 99.2% on a claimed 98.5%, and the trend is the interesting part — and a number…
Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.
Independent testing plus vendor-level trend data. Community-funded, unaffiliated.
peptidemeter.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference